EGFR and lung adenocarcinoma: In this study, we found that the SUV entropy measured from the pretreatment 18F-FDG PET was independently associated with the time-to-progression of EGFR-targeted TKI treatment and the OS in patients with lung adenocarcinoma harboring EGFR mutations.